Breaking News Instant updates and real-time market news.

FANG

Diamondback Energy

$133.75

1.84 (1.39%)

, EGN

Energen

$73.15

1.76 (2.47%)

16:19
08/14/18
08/14
16:19
08/14/18
16:19

Diamondback Energy to acquire Energen in all-stock transaction

Diamondback Energy (FANG) and Energen (EGN) announced that they have entered into a definitive agreement under which Diamondback will acquire Energen in an all-stock transaction valued at approximately $9.2B, including Energen's net debt of $830 million as of June 30, 2018. The consideration will consist of 0.6442 shares of Diamondback common stock for each share of Energen common stock, representing an implied value to each Energen shareholder of $84.95 per share based on the closing price of Diamondback common stock on August 13, 2018. The transaction was unanimously approved by the Board of Directors of each company."This transaction represents a transformational moment for both Diamondback and Energen shareholders as they are set to benefit from owning the premier large cap Permian independent with industry leading production growth, operating efficiency, margins and capital productivity supporting an increasing capital return program. The Energen team has done an outstanding job assembling a portfolio of Tier One acreage in both the Midland and Delaware basins, which, when combined with Diamondback's current portfolio, will present an extended runway for Diamondback's record of best-in-class execution and low-cost operations. This transaction also adds critical mass for driving capital efficiencies in what is now truly becoming a manufacturing business. I expect the pro forma company to be able to grow at industry leading rates while returning capital at a competitive yield," stated Travis Stice, Chief Executive Officer of Diamondback.

FANG

Diamondback Energy

$133.75

1.84 (1.39%)

EGN

Energen

$73.15

1.76 (2.47%)

FANG Diamondback Energy
$133.75

1.84 (1.39%)

06/19/18
JEFF
06/19/18
NO CHANGE
Target $177
JEFF
Buy
Diamondback Energy price target raised to $177 from $170 at Jefferies
Jefferies analyst Mark Lear raised his price target for Diamondback Energy to $177 after a new slide presentation provided detail on the company's new marketing arrangements that assure 70% of gross projected volumes move to the Gulf Coast in the second half of 2018 and 2019. The analyst notes that the deal locks in $5.5 per barrel better pricing in the second half of 2018 and $4 per barrel better in the first half of 2019 compared to his prior estimates. Diamondback's transportation agreements not only assure volume growth through 2019 but also lock in better pricing relative to Midland-Cushing basis futures, Lear tells investors in a research note.He keeps a Buy rating on the shares.
06/20/18
RHCO
06/20/18
NO CHANGE
Target $165
RHCO
Buy
Diamondback Energy pullback offers buying opportunity, says SunTrust
SunTrust analyst Neal Dingmann kept his Buy rating and $165 price target on Diamondback Energy, saying the 7% selloff in the stock price relative to the 2% gain in the Oil&Gas Exploration Sector ETF offers a buying opportunity for investors. The analyst cites the company's recently announced transportation oil agreements to the Gulf Coast to go along with its industry leading operations, adding that 70% of its production will have a fixed discount to Gulf pricing by the end of Q3. Dingmann also states that Diamondback Energy continues to generate industry leading well returns thanks to its strong rates and low operating costs.
08/03/18
GSCO
08/03/18
DOWNGRADE
Target $21
GSCO
Neutral
WPX Energy downgraded to Neutral from Conviction Buy at Goldman Sachs
Goldman Sachs analyst John Nelson downgraded WPX Energy (WPX) to Neutral and removed the shares from his firm's Conviction List. The analyst believes the company's secular growth outlook remains intact and cites valuation for the downgrade. WPX's valuation is less differentiated at current share levels, and investors should rotate into Diamondback Energy (FANG) and PDC Energy (PDCE), which offer greater upside potential, Nelson tells investors in a research note. The analyst has a $21 price target for WPX shares.
08/14/18
STFL
08/14/18
NO CHANGE
Target $38
STFL
Hold
Viper Energy price target raised to $38 from $32 at Stifel
Stifel analyst Timothy Howard raised his price target for Viper Energy (VNOM) to $38 from $32 after the company posted above-expectation results for Q2 last week, telling investors in a research note that results were less impacted by differentials than had been assumed and given recent commentary by Diamondback Energy (FANG), he believes Viper's exposure is largely capped. Howard maintains a Hold rating on the shares.
EGN Energen
$73.15

1.76 (2.47%)

07/12/18
MSCO
07/12/18
DOWNGRADE
MSCO
Equal Weight
Energen downgraded to Equal Weight from Overweight at Morgan Stanley
07/12/18
07/12/18
DOWNGRADE
Target $76

Equal Weight
Energen downgraded to Equal Weight on valuation at Morgan Stanley
As previously reported, Morgan Stanley analyst Drew Venker downgraded Energen to Equal Weight from Overweight citing valuation after the stock's year-to-date outperformance compared to its Permian Basin peers. He lowered his price target on Energen shares to $76 from $93.
07/20/18
WILL
07/20/18
DOWNGRADE
WILL
Hold
Energen downgraded to Hold from Buy at Williams Capital
08/08/18
IMPC
08/08/18
DOWNGRADE
Target $74
IMPC
In-Line
Energen downgraded to In-Line from Outperform at Imperial Capital
Imperial Capital analyst Irene Haas downgraded Energen to In-Line with an unchanged price target of $74. The analyst views the company's Q2 results as "strong" but finds the stock fairly valued at current levels.

TODAY'S FREE FLY STORIES

ACIU

AC Immune

$11.58

0.63 (5.75%)

, LLY

Eli Lilly

$114.49

0.38 (0.33%)

06:32
12/12/18
12/12
06:32
12/12/18
06:32
Hot Stocks
AC Immune, Eli Lilly announce license and collaboration agreement »

AC Immune (ACIU) and Eli…

ACIU

AC Immune

$11.58

0.63 (5.75%)

LLY

Eli Lilly

$114.49

0.38 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

OMI

Owens & Minor

$7.11

-0.19 (-2.60%)

06:32
12/12/18
12/12
06:32
12/12/18
06:32
Hot Stocks
Owens & Minor names Robert Snead as EVP & CFO »

Owens & Minor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKH

Black Hills

$67.28

0.06 (0.09%)

06:31
12/12/18
12/12
06:31
12/12/18
06:31
Downgrade
Black Hills rating change  »

Black Hills downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMR

Emerson

$62.30

-0.28 (-0.45%)

06:30
12/12/18
12/12
06:30
12/12/18
06:30
Downgrade
Emerson rating change  »

Emerson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ES

Eversource

$70.18

0.53 (0.76%)

06:30
12/12/18
12/12
06:30
12/12/18
06:30
Downgrade
Eversource rating change  »

Eversource downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

GOOG

Alphabet

$1,051.82

11.8 (1.13%)

, GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

06:29
12/12/18
12/12
06:29
12/12/18
06:29
Periodicals
Google CEO faces questions from lawmakers on alleged political bias, WSJ says »

Google CEO Sundar Pichai…

GOOG

Alphabet

$1,051.82

11.8 (1.13%)

GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

CS

Credit Suisse

$10.92

-0.09 (-0.82%)

06:27
12/12/18
12/12
06:27
12/12/18
06:27
Hot Stocks
Credit Suisse sees FY18 reported pre-tax income CHF3.2B-CHF3.4B »

Sees FY18 APAC Markets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CS

Credit Suisse

$10.92

-0.09 (-0.82%)

06:25
12/12/18
12/12
06:25
12/12/18
06:25
Hot Stocks
Credit Suisse board approves buyback of up to CHF1.5B »

At its 2018 investor day,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAR

Marriott

$110.04

-0.78 (-0.70%)

06:22
12/12/18
12/12
06:22
12/12/18
06:22
Periodicals
Chinese hackers behind Marriott data breach, NY Times reports »

The cyberattack on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.40

-1.46 (-2.44%)

06:20
12/12/18
12/12
06:20
12/12/18
06:20
Initiation
Six Flags initiated  »

Six Flags initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,051.82

11.8 (1.13%)

, GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

06:20
12/12/18
12/12
06:20
12/12/18
06:20
Periodicals
Snowden, others call for Pichai to kill Google's 'Project Dragonfly,' BI reports »

NSA whistleblower Edward…

GOOG

Alphabet

$1,051.82

11.8 (1.13%)

GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

BY

Byline Bancorp

$18.91

-0.32 (-1.66%)

06:18
12/12/18
12/12
06:18
12/12/18
06:18
Conference/Events
Byline Bancorp management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RY

Royal Bank of Canada

$69.76

-0.44 (-0.63%)

06:17
12/12/18
12/12
06:17
12/12/18
06:17
Upgrade
Royal Bank of Canada rating change  »

Royal Bank of Canada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

CORT

Corcept Therapeutics

$17.16

4.18 (32.20%)

06:17
12/12/18
12/12
06:17
12/12/18
06:17
Upgrade
Corcept Therapeutics rating change  »

Corcept Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$116.67

1.66 (1.44%)

06:17
12/12/18
12/12
06:17
12/12/18
06:17
Upgrade
Lululemon rating change  »

Lululemon upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

BBY

Best Buy

, AMZN

Amazon.com

$1,643.50

3.13 (0.19%)

06:16
12/12/18
12/12
06:16
12/12/18
06:16
Recommendations
Best Buy, Amazon.com analyst commentary  »

Best Buy…

BBY

Best Buy

AMZN

Amazon.com

$1,643.50

3.13 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

KRYS

Krystal Biotech

$23.49

0.38 (1.64%)

06:16
12/12/18
12/12
06:16
12/12/18
06:16
Initiation
Krystal Biotech initiated  »

Krystal Biotech initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOMX

Foamix

$3.81

-0.19 (-4.75%)

06:13
12/12/18
12/12
06:13
12/12/18
06:13
Initiation
Foamix initiated  »

Foamix initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

, RNSDF

Renault

$0.00

(0.00%)

06:13
12/12/18
12/12
06:13
12/12/18
06:13
Periodicals
Nissan shares detailed allegations against Ghosn with Renault, FT reports »

Nissan (NSANY) has shared…

NSANY

Nissan

$0.00

(0.00%)

RNSDF

Renault

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

BHC

Bausch Health

$23.09

0.25 (1.09%)

, SGYP

Synergy Pharmaceuticals

$0.34

-0.0094 (-2.69%)

06:13
12/12/18
12/12
06:13
12/12/18
06:13
Hot Stocks
Bausch Health to acquire Synergy Pharmaceuticals for $200M through Chapter 11 »

Synergy Pharmaceuticals…

BHC

Bausch Health

$23.09

0.25 (1.09%)

SGYP

Synergy Pharmaceuticals

$0.34

-0.0094 (-2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 25

    Feb

EADSY

Airbus

$0.00

(0.00%)

06:11
12/12/18
12/12
06:11
12/12/18
06:11
Periodicals
Airbus staff error led to fatal 2017 German helicopter crash, Reuters reports »

The fatal crash in 2017…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEY

KeyCorp

$15.93

-0.075 (-0.47%)

06:09
12/12/18
12/12
06:09
12/12/18
06:09
Downgrade
KeyCorp rating change  »

KeyCorp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

06:07
12/12/18
12/12
06:07
12/12/18
06:07
Periodicals
Senate confirms Muzinich as Deputy Treasury Secretary, WSJ reports »

The Senate has confirmed…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLAY

Dave & Buster's

$51.08

-1.44 (-2.74%)

06:07
12/12/18
12/12
06:07
12/12/18
06:07
Recommendations
Dave & Buster's analyst commentary  »

Dave & Buster's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

LLY

Eli Lilly

$114.49

0.38 (0.33%)

, ACIU

AC Immune

$11.58

0.63 (5.75%)

06:06
12/12/18
12/12
06:06
12/12/18
06:06
Hot Stocks
Eli Lilly, AC Immune to develop tau aggregation inhibitor small molecules »

Eli Lilly (LLY) and AC…

LLY

Eli Lilly

$114.49

0.38 (0.33%)

ACIU

AC Immune

$11.58

0.63 (5.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.